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Objective: The aim of the study was to evaluate the association between prevalence and severity of
radiographic hand osteoarthritis (OA) and serum levels of systemic inﬂammatory markers in a commu-
nity-based population sample.
Design: A cross-sectional observational study was conducted on a population comprised 1452 Chuva-
shians (763 males, aged 49.23 17.43; and 689 females, aged 50.37 17.47 years). OA was evaluated in
14 joints of each hand using Kellgren and Lawrence (KeL), joint space narrowing (JSN) and osteophyte
(OS) scores. Serum levels of systemic inﬂammatory and osteoclastogenic cytokines were measured by an
enzyme-linked immunosorbent assay (ELISA). Statistical analyses included descriptive statistics, corre-
lation analysis and multiple linear regressions.
Results:Monocyte chemotactic protein-1 (MCP-1) and osteoprotegerin (OPG) levels were associated with
OA traits, but the statistically signiﬁcant correlations were weak and/or moderate. In particular, the MCP-
1 inﬂammation marker showed a statistically signiﬁcant association with JSN (b¼ 0.077, P¼ 0.022) and
OS (b¼ 0.067, P¼ 0.024) scores, but not with the number of affected joints (KeL 2). OPG was signiﬁ-
cantly correlated with the scores as to the number of affected joints (b¼ 0.063, P¼ 0.035) and OS
(b¼ 0.077, P¼ 0.028). No signiﬁcant associations were found between levels of other inﬂammatory
[interleukin (IL)-6, tumor necrosis factor (TNF)-a, IL-17] and osteoclastogenic [receptor activator for
nuclear factor k B ligand (RANKL), macrophage colony-stimulating factor (M-CSF)] cytokines and OA
characteristics.
Conclusions: This study strengthens the premise that OPG might be a valid biomarker of hand OA.
Conﬁrmation of these results in larger cohorts of patients will reinforce our theory that the RANKL/OPG
pathway is a suitable target for developing novel agents against OA.
 2010 Published by Elsevier Ltd on behalf of Osteoarthritis Research Society International.Introduction
Osteoarthritis (OA) is the most common form of arthritis and
can result in substantial disability in the elderly1. Although OA is
generally described as a non-inﬂammatory disease, various studies
have indicated that the presence of intraarticular low-grade
inﬂammation contributes to the development and progress of OA2.
Recent in-vivo and in-vitro studies have demonstrated that chon-
drocytes can produce and/or respond to a number of inﬂammatoryEugene Kobyliansky, Human
Anatomy and Anthropology,
t Aviv 69978, Tel Aviv, Israel.
iansky).
Elsevier Ltd on behalf of Osteoartcytokines and chemokines present in joint tissues and ﬂuids in
OA3e7.
Interleukin (IL)-1 and tumor necrosis factor (TNF)-a appear to
play predominant roles in the initiation and progression of articular
cartilage destruction3e5 by decreasing collagen synthesis and
increasing the levels of matrix metalloproteinases (MMPs)8, and of
other inﬂammatory mediators, such as nitric oxide, IL-8, IL-6, and
prostaglandin E29. Subsequently, nitric oxide inﬂuences the chon-
drocytes, thus promoting cartilage degradation, including inhibi-
tion of collagen and proteoglycan synthesis, MMP activation8, and
increased susceptibility to other oxidant injury4,10.
The role of IL-6 in inﬂammation differs from that of TNF. IL-6
levels rise in various inﬂammatory conditions and bone resorp-
tion6,7. Serum concentrations of inﬂammatory markers such as C
reactive protein (CRP) and IL-6 are higher among persons with kneehritis Research Society International.
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the role of IL-6 in cartilage pathology remains unclear, as this
cytokine can induce the production of tissue inhibitors of metal-
loperoxidase-1 (TIMP), IL-1 receptor antagonists (IL-1Ra), and
soluble TNF receptors, all of which inhibit or blockMMP or cytokine
activity.
Among other cytokines, it has been suggested that IL-17 and IL-
18 play a role in OA pathophysiology, as they share many properties
with IL-112. These cytokines also affect an articular tissue, inde-
pendent of IL-1b. Both seem to be involved in the early phases of
the inﬂammatory process13,14.
Moreover, in addition to the inﬂammatory cytokines, there is
ample evidence of involvement of the chemokine system in the
pathogenesis of OA15e17. For example, chemokines were detected in
OA synovial ﬂuid and were shown to be expressed in synoviocytes
and subchondral bone osteoblasts15,17. The investigators also
revealed that human chondrocytes express mRNA of several che-
mokines, including IL-8, monocyte chemotactic protein-1/chemo-
kine (C-C motif) ligand 2 (MCP-1/CCL2) and release these
chemokines at various levels15. Increased production of MCP-1 and
Regulated upon Activation, Normal T-cell Expressed, and Secreted
(RANTES) in OA chondrocytes has also been reported18.
On the other hand, synovial inﬂammation is not the primary
cause of OA, but rather a secondary phenomenon related to
multiple factors including matrix degradation19,20. Recent studies
have conﬁrmed that the subchondral bone is the site of several
dynamic morphological and biochemical changes that appear to be
part of the OA process19,20. Factors such as osteoprotegerin (OPG)
and receptor activator for nuclear factor k B ligand (RANKL), which
constitute speciﬁc components capable of inﬂuencing the bone
remodeling process, have also been found to be expressed and
modulated in human OA subchondral bone. Moreover, it was
recently demonstrated that during longstanding OA and rheuma-
toid arthritis, the OPG/RANKL ratio in the synovial ﬂuid is far more
elevated in OA than in rheumatoid arthritis21.
Thus, it is widely accepted that both chemokines, proin-
ﬂammatory and osteoclastogenic cytokines play important roles in
OA pathogenesis. The levels of many of these mediators probably are
a more dominant determinant in net cartilage destruction than
absolute levels of destructive mediators such as IL-1. Consequently,
we hypothesize that the circulating levels of inﬂammatory and
osteoclastogenic cytokines i.e.,MCP-1, IL-17, IL-6, TNF-a, OPG, RANKL,
and macrophage colony-stimulating factor (M-CSF) might be inde-
pendentlyassociatedwith radiographichandOAandcouldbeusedas
biomarkers of disease development or severity. We previously
reported on plasma levels of cytokines and the inﬂuence of genetic
and environmental factors on circulating levels of IL-6, TNF-a, MCP-1,
RANKL/OPG/M-CSF22e25, but the current study constitutes the ﬁrst
investigation of the correlation of key markers of inﬂammation and
osteoclastogenesis with OA characteristics and cytokine levels.
Materials and methods
Study sample
The study population comprised native Chuvashians residing in
a number of small villages in the Republics of Chuvashia and
Bashkortostan, Russian Federation. Our aim was to investigate
skeletal aging for which the study design (cross-sectional obser-
vation study) and data collection methods have been described
previously26. The data were gathered during three expeditions
undertaken in August/September 1994, May/June 1999, and
September 2002 by the Anuchin Research Institute and Museum of
Anthropology, Moscow State University (Russia) and the Depart-
ment of Anatomy and Anthropology, Sackler Faculty of Medicine,Tel Aviv University (Israel). The same team of investigators
collected the data and performed all the measurements during all
three expeditions.
The collected data included basic socioeconomic parameters,
medical history, and standard anthropometric measurements; in
addition, plain hand radiographs of both hands and blood samples
were obtained from all subjects. The study participants had no
chronic or acute infections, metabolic diseases or primary or
secondary pathologic amenorrhea, and were not receiving
prescription or non-prescription anti-inﬂammatory drugs, or vita-
mins, minerals or other dietary supplements on a regular basis. All
tested subjects signed an informed consent form. The study was
approved by the Ethics Committee of Tel Aviv University, Israel.
Cytokine measurements
Blood samples were obtained by venepuncture from subjects
who had fasted overnight. Cells were removed by centrifugation,
and serum aliquots were stored at 80C until analyzed. Plasma
levels of TNF-a and IL-6 were determined using a high-sensitivity
commercial enzyme-linked immunosorbent assay (ELISA) with an
alkaline phosphatase signal ampliﬁcation system for TNF-a and IL-6
(Quantikine High-Sensitivity ELISA, Minneapolis, MN, USA). All
measurements were carried out in accordance with the manufac-
turers’ instructions and implemented using amicroplate reader. The
results were calculated using a four-parameter curve ﬁt and
expressed as pg/ml. The intra-assay coefﬁcient of variation was 6%;
the inter-assay coefﬁcient of variation was 10%. The minimum
detection doses for TNF-awere 0.32 pg/ml and for IL-6, 0.094 pg/ml.
MCP-1, IL-17, OPG, RANKL, and M-CSF levels were determined
by a sandwich enzyme immunoassay technique using a set of
speciﬁc antibodies and standards from R&D Systems. The detection
limit was 15.6 pg/ml forMCP-1, 40 pg/ml for OPG for IL-17, 20 pg/ml
for sRANKL and 9 pg/ml for M-CSF. The inter- and intra-assay
variations were less than 4.7% and 10%, respectively. All hormones
and biochemical markers were assayed in duplicate. Mean values
were used in further analyses.
Radiographic assessment of OA
Single plain radiograms of both hands were obtained from each
study participant in a postero-anterior position, with the X-ray
source located 60 cm above the hand, as described in detail by
Pavlovsky in 198127. The hands were exposed for 5e10 s at
100e150 mA, without intensifying screens, at 50 kV. The same
equipment was used in all three expeditions and X-rays were taken
according to the same standardized protocol.
Each X-ray was read by an experienced, specially trained
researcher. The degree of OA was evaluated in 14 joints of each
hand [four distal interphalangeal (DIP), four proximal interpha-
langeal (PIP), ﬁve metacarpophalangeal (MP), and ﬁrst interpha-
langeal (IP-1) joints], according to Kellgren and Lawrence’s (KeL)
grading criteria, utilizing photographs from the Atlas of Standard
Radiographs28. In addition, joint space narrowing (JSN) and
osteophyte (OS) formation of the same joints were evaluated using
the Atlas of Altman and Gold29. The KeL index for each joint ranged
from 0 to 4, with those scored as KeL 2 considered as affected.
The JSN and OS indices ranged from 0 to 3, with scores JSN 2 or
OS 2 considered as affected.
In the present study, we used six indices of radiographic hand
OA: (1) three indices of the number of affected joints for each
individual (designated Num-KL, Num-JSN and Num-OS) repre-
senting severity of hand OA; and (2) three indices of the presence of
at least one affected joint (dichotomous indices) (designated Dich-
KL, Dich-JSN and Dich-OS).
Table I
Descriptive statistics for all studied traits (mean and 95% conﬁdence interval for
mean, upper and lower limit)
n Men n Women
Age (years) 763 49.23 [47.99e50.47] 689 50.37 [49.13e51.61]
Height (m) 763 1.66 [1.66e1.66] 689 1.55 [1.55e1.55]
Weight (kg) 763 64.60 [63.80e65.40] 689 61.06 [60.15e61.97]
BMI (kg/m2) 763 23.32 [23.07e23.57] 689 25.53 [25.17e25.89]
MCP-1 (pg/ml) 479 84.65 [79.16e90.14] 413 81.30 [76.34e86.26]
IL-17 (pg/ml) 141 12.97 [9.09e16.85] 141 14.25 [10.89e17.61]
IL-6 (pg/ml) 211 2.51 [2.15e2.87] 209 2.25 [1.92e2.58]
TNF-a (pg/ml) 212 4.90 [3.91e5.89] 209 4.67 [3.70e5.64]
OPG (pg/ml) 459 2974.36 [2873.14e
3075.59]
393 2966.47 [2854.14e
3078.80]
RANKL (pg/ml) 471 1109.82 [1020.86e
1198.78]
400 1216.13 [213.89e
2218.37]
M-CSF (pg/ml) 212 845.31 [791.28e899.34] 209 938.22 [846.65e
1029.79]
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Two experienced researchers (an orthopedic surgeon and
a researcher experienced in radiograph reading) read sets of
radiographs and decided on the protocol for evaluating the KeL
scores. Ten X-rays were read using this protocol and then re-read
separately by two investigators to estimate the intra- and inter-
rater reliability of the readings. All discrepancies were reviewed for
systematic errors. This procedure continued for 10 different sets of
radiographs until high intra- and inter-rater reliability (k> 0.80)
was established. Thereafter, one investigator read all the X-rays,
blinded to the patient’s name, sex and age. Before reading each set
of radiographs, the investigator re-read ﬁve previously read
radiographs to “calibrate” his readings to a standard. The intra-rater
reliability (k statistics) for KeL scores was 0.84 (P< 0.01), for JSN
scores 0.82 (P< 0.01) and for OS scores 0.91 (P< 0.01) based on 20
repeated measurements.Body mass index (BMI)
BMI was computed as the ratio of weight (in kilograms) divided
by height (in meters) squared.Statistical analysis
Preliminary descriptive statistics, including mean, standard
deviation (SD), and Pearson correlations were performed using the
STATISTICA 8.0 statistical package (Statsoft, Inc, USA). Initial anal-
yses revealed statistically signiﬁcant deviations from the norm in
the data distribution of some cytokines. These data were thus log-
transformed prior to further analyses. Thereafter, the correlations
between each biochemical index and age, sex, and BMI were
calculated. In the female sub-sample, all correlations were ﬁrstTable II
Coefﬁcients of regression between the inﬂammation biomarkers and age and BMI, accor
Biomarker n Men
Age BMI
MCP-1 479 0.108 [0.020e0.196] 0.101 [0.017e0.197]
IL-17 141 0.070 [0.229e0.089] 0.071 [0.091e0.231
IL-6 211 0.253 [0.120e0.386] 0.003 [0.138e0.132
TNF-a 212 0.067 [0.202e0.068] 0.136 [0.271 to 0
OPG 459 0.473 [0.379e0.567] 0.086 [0.008e0.180
RANKL 471 0.080 [0.172e0.012] 0.025 [0.069e0.119
M-CSF 212 0.277 [0.146e0.408] 0.136 [0.001e0.271]
Signiﬁcant correlations (P 0.05) are shown in bold type.separately evaluated in premenopausal and postmenopausal
women. Since no statistical differences were found in the pattern
and extent of correlations, all further analyses of female partici-
pants were performed without considering menopausal status. For
numerical OA indexes, multiple regression models were built with
following predictors: age, sex, BMI and biochemical marker
concentration (separately for each marker).
Results
Descriptive statistics and sex differences
The main characteristics of the sample population are shown in
Table I, presented before log-transformation, in their original units.
Average ages of the participants were 49.2 years for the men and
50.4 years for the women. The mean BMI was 23.3 and 25.5 kg/m2
for men and women, respectively. The variation span of the vari-
ables for each sex, in the present study was within normal variation
range. Testing the distribution of each of the biochemical factors
using Fallon et al.’s method30 indicated that individuals with
a mean more than four SDs were clearly outliers in the general or
the sex-speciﬁc samples. These outliers (N¼ 10) were therefore
omitted from the subsequent statistical analysis. There were no
signiﬁcant differences between men and women in the mean
concentrations of the studied cytokines (ManneWhitney U test,
P> 0.10). For both sexes, the distributions of all measured
biochemical indices showed statistically signiﬁcant deviations from
the norm, and were consequently subjected to logarithmic trans-
formation. Statistical data for the other studied biochemical indices
(Table I) will not be discussed at present since this was recently
performed elsewhere23e26.
Age-dependent trends of studied variables
The inﬂuence of age and BMI on each of the studied variables
showed that for both sexes the plasma levels of MCP-1, IL-6, and
OPG signiﬁcantly changed with age P< 0.001 (Table II). The extent
of M-CSF correlation with age was greater in women (r¼ 0.29,
P< 0.001) than in men (r¼ 0.17, P¼ 0.012), with no signiﬁcant
difference (P> 0.05). OPG was similar in both sexes (r¼ 0.42e0.43,
P< 0.001), while there was no correlation between age and IL-17,
RANKL and TNF-a levels for both sexes. There were small but
signiﬁcant regression coefﬁcients between BMI and MCP-1 and
OPG (Table II).
Interrelationship between OA characteristics and the inﬂammatory
markers
An investigation of possible associations between OA charac-
teristics (Num-KL; Dich-KL) and cytokine plasma levels revealed
that there was no signiﬁcant association (P> 0.05) between OAding to sex (b with 95% conﬁdence interval, upper and lower limit)
n Women
Age BMI
413 0.212 [0.122e0.302] 0.110 [0.022e0.198]
] 141 0.038 [0.205e0.129] 0.035 [0.132e0.202]
] 209 0.210 [0.079e0.341] 0.054 [0.079e0.187]
.001] 209 0.017 [0.152e0.118] 0.021 [0.156e0.114]
] 393 0.556 [0.478e0.634] 0.219 [0.125e0.313]
] 400 0.081 [0.174e0.014] 0.034 [0.128e0.060]
209 0.195 [0.064e0.326] 0.127 [L0.006e0.260]
Table III
Coefﬁcients of regression between the OA characteristics and inﬂammation biomarkers, age and BMI in males (b with 95% conﬁdence interval, upper and lower limit)
Men (n) Num-KL Num-JSN Num-OS Dich-KL Dich-JSN Dich-OS
Age (763) 0.648 [0.595e0.701] 0.196 [0.125e0.267] 0.531 [0.470e0.592] 0.727 [0.678e0.776] 0.318 [0.251e0.385] 0.674 [0.621e0.727]
BMI (763) 0.201 [0.130e0.272] 0.069 [0.003e0.142] 0.115 [0.043e0.187] 0.164 [0.092e0.236] 0.079 [0.006e0.151] 0.113 [0.041e0.185]
MCP-1 (479) 0.119 [0.027e0.210] 0.135 [0.044e0.226] 0.070 [0.022e0.161] 0.029 [0.062e0.121] 0.041 [0.051e0.132] 0.013 [0.079e0.105]
IL-17 (141) 0.078 [0.241e0.085] 0.016 [0.147e0.180] 0.024 [0.138e0.188] 0.065 [0.228e0.098] 0.016 [0.147e0.180] 0.042 [0.121e0.206]
IL-6 (211) 0.198 [0.064e0.336] 0.111 [0.026e0.250] 0.103 [0.035e0.241] 0.208 [0.073e0.344] 0.094 [0.044e0.232] 0.192 [0.056e0.329]
TNF-a (212) 0.099 [0.237e0.038] 0.071 [0.209e0.067] 0.087 [0.225e0.051] 0.023 [0.115e0.162] 0.006 [0.145e0.130] 0.066 [0.205e0.071]
OPG (459) 0.346 [0.256e0.433] 0.120 [0.027e0.214] 0.282 [0.192e0.373] 0.356 [0.264e0.441] 0.130 [0.037e0.224] 0.3235 [0.235e0.413]
RANKL (471) 0.066 [0.160e0.027] 0.073 [0.167e0.021] 0.070 [0.164e0.024] 0.048 [0.142e0.046] 0.089 [0.183e0.005] 0.033 [0.128e0.060]
M-CSF (212) 0.202 [0.067e0.338] 0.012 [0.126e0.151] 0.118 [0.019e0.256] 0.262 [0.128e0.395] 0.022 [0.117e0.161] 0.162 [0.025e0.299]
Signiﬁcant correlations (P 0.05) are shown in bold type.
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men and women (Tables III and IV). Only MCP-1, IL-6 and OPGwere
associated with OA traits, however the statistically signiﬁcant
correlations were weak and/or moderate. For testing the effects of
age, BMI and cytokines on the degree of OA, multiple regression
analysis was performed only for traits signiﬁcantly correlated with
OA. The results showed that only MCP-1 and OPG are signiﬁcant
predictors of the degree of OA, while the other cytokines have no
signiﬁcant effect (Table V).
An examination of the association between the studied cyto-
kines showed that there were highly statistically signiﬁcant
correlations between plasma concentrations of RANKL and MCP-1
in both sexes (r¼ 0.24, P< 0.001). In addition, there was
a moderate, but signiﬁcant, association between MCP-1 and OPG
levels in the sub-sample of women (r¼ 0.19, P< 0.01).Discussion
Alterations in OA cartilage are related to changes in chondrocyte
metabolism. The course of the destructive process is determined by
the balance between anabolic and catabolic mediators and their
regulators in the joint and by the local distribution of these medi-
ators in the cartilage3,4. At present, conventional radiography is
considered the gold standard in diagnosing OA; however, it cannot
detect early stages of OA or monitor OA progression over a short
period of time. To overcome these limitations, the search for valid
biomarkers has intensiﬁed over recent years3,6e10,12,31.
The molecular triad, OPG/RANK/RANKL, has been described as
a key cytokine system for controlling the differentiation and func-
tion of osteoclasts. The balance between the expression of RANKL
and OPG determines the extent of osteoclast activity and subse-
quent bone resorption19,20. Furthermore, in rheumatoid arthritis,
the sRANKL/OPG ratio in both mRNA and protein level is increased
in synovial ﬂuid/blood and leads to bone destruction observed in
this disease20,21. It has also been demonstrated that the ratios of
OPG/RANKL and RANK/RANKL in OA chondrocytes are signiﬁcantly
different from those in normal chondrocytes21.Table IV
Coefﬁcients of regression between the OA characteristics and inﬂammation biomarkers,
Women (n) Num-KL Num-JSN Num-OS
Age (689) 0.650 [0.592e0.709] 0.169 [0.094e0.245] 0.491 [0.424e0.55
BMI (689) 0.218 [0.143e0.294] 0.086 [0.009e0.163] 0.074 [0.003e0.1
MCP-1 (413) 0.155 [0.063e0.248] 0.046 [0.047e0.140] 0.201 [0.110e0.29
IL-17 (141) 0.041 [0.127e0.210] 0.001 [0.168e0.170] 0.028 [0.196e0.1
IL-6 (209) 0.204 [0.072e0.336] 0.152 [0.018e0.285] 0.168 [0.035e0.30
TNF-a (209) 0.012 [0.123e0.147] 0.075 [0.060e0.209] 0.032 [0.103e0.1
OPG (393) 0.408 [0.321e0.496] 0.116 [0.020e0.211] 0.310 [0.219e0.40
RANKL (400) 0.030 [0.065e0.124] 0.020 [0.115e0.074] 0.012 [0.082e0.1
M-CSF (209) 0.250 [0.119e0.381] 0.099 [0.035e0.233] 0.109 [0.025e0.2
Signiﬁcant correlations (P 0.05) are shown in bold type.Therefore, in the present study, we set out to evaluate the
relationship between proinﬂammmatory and osteoclastogenic
cytokines and OA characteristics. We found MCP-1 and OPG to be
important predictors of OA development. However, no signiﬁcant
associations between inﬂammatory markers, osteoclastogenic
cytokines (IL-6, TNF-a, IL‑17, RANKL, and M-CSF) and OA charac-
teristics were found.
Our results are in partial agreement with Pilichou et al.22 and
Toncheva et al.’s32 ﬁndings. Pilichou et al. demonstrated that patients
with OA of the knee had higher serum levels of OPG and sRANKL and
that the local production of OPG strongly correlated with the radio-
logical disease severity of OA19,21. Toncheva et al.32 showed that the
sRANKL serum increased in both active and inactive OA patients.
However, this elevation was less in active OA, pointing to the possi-
bility that certain mechanisms inhibiting sRANKL are triggered
during the active phase32. Consequently, we could conclude that the
increase of OPG levels reﬂect a compensatory response by chon-
drocytes,macrophages or synovialﬁbroblasts as to sRANKL elevation
and protecting the joint, albeit ineffectively. On the other hand, Vlad
et al.33 found no evidence of an association between any of the
inﬂammatory markers and presence of radiographic OA.
The results of our study reveal that the levels of the inﬂammation
marker MCP-1 are associated with Num-JSN and Num-OS (Table V).
We also showed that MCP-1 levels are signiﬁcantly correlated
(P< 0.01) with RANKL in both sexes and with OPG in women. The
association between the osteoclastogenic cytokines and MCP-1
levels in healthy pedigrees is of special interest, since it could shed
light on the involvement of MCP-1 in cartilage and bone remodeling.
Major strengths of this study: (1) we examined an ethnically,
culturally and socio-economically homogeneous population, with
phenotype measurements unchanged by the intake of medications
or vitamin supplements; (2) the examined individuals were free of
acute and chronic immune-related diseases (autoimmune, cancer
etc); (3) each individual was simultaneously assessed for all of the
examined variables.
On the other hand, our study had several limitations. Firstly,
levels of markers in and around joints were not measured. We doage and BMI in females (b with 95% conﬁdence interval, upper and lower limit)
Dich-KL Dich-JSN Dich-OS
8] 0.711 [0.657e0.765] 0.257 [0.183e0.331] 0.596 [0.534e0.658]
51] 0.164 [0.088e0.240] 0.026 [0.051e0.104] 0.073 [0.004e0.150]
3] 0.107 [0.014e0.200] 0.056 [0.037e0.149] 0.147 [0.054e0.239]
41] 0.020 [0.189e0.148] 0.039 [0.129e0.208] 0.039 [0.208e0.129]
2] 0.109 [0.026e0.243] 0.152 [0.018e0.285] 0.133 [0.001e0.266]
67] 0.012 [0.123e0.147 0.074 [0.060e0.209] 0.055 [0.080e0.190]
1] 0.400 [0.312e0.487] 0.178 [0.083e0.272] 0.345 [0.255e0.435]
07] 0.041 [0.135e0.054] 0.001 [0.095e0.094] 0.076 [0.170e0.018]
43] 0.140 [0.006e0.273] 0.099 [0.035e0.233] 0.090 [0.044e0.225]
Table V
Results of multiple regression analyses for Num-KL, Num-JS, Num-OS as dependent variables for single biochemical marker concentration and sex, age and BMI as predictors
(bþ SE is given for the biochemical marker variable; R2 is given for the whole model)
N MCP-1 IL-17 IL-6 TNF OPG RANKL M-CSF
892 282 420 421 852 871 420
Num-KL b 0.029 0.025 0.000 0.041 0.049 0.036 0.011 0.035 0.063 0.029 0.045 0.025 0.068 0.036
P 0.238 0.990 0.169 0.763 0.035 0.068 0.059
R2 0.439 0.517 0.482 0.481 0.456 0.456 0.484
Num-JS b 0.077 0.033 0.038 0.057 0.085 0.049 0.003 0.048 0.060 0.040 0.017 0.033 0.002 0.049
P 0.022 0.051 0.086 0.937 0.131 0.603 0.972
R2 0.019 0.089 0.048 0.041 0.026 0.025 0.042
Num-OS b 0.067 0.029 0.011 0.053 0.042 0.045 0.004 0.044 0.077 0.035 0.018 0.029 0.009 0.045
P 0.024 0.830 0.395 0.920 0.028 0.528 0.836
R2 0.250 0.211 0.187 0.183 0.246 0.239 0.185
N e number of measured individuals. For all regression models R2 is signiﬁcant P< 104; models with signiﬁcant biochemical marker inﬂuence (P< 0.05) are shown in
bold type.
I. Pantsulaia et al. / Osteoarthritis and Cartilage 18 (2010) 1448e14531452not knowwhether circulating levels of these markers may correlate
well with local levels. However, since osteoarthritic cartilage is the
site of increased production of both cytokines and chemokines,
including IL-8, monocyte chemoattractant protein-1, and RANTES,
IL-615e18, we were unable to reveal the main sources of increased
levels of MCP-1 and OPG. We note that Stankovic et al. demon-
strated that synovial ﬂuid leukocytes are important sources of
chemokines34. Secondly, measurements of the same individuals
before and after OA development were not taken, due to the cross-
sectional design of our study. Thirdly, we evaluated only radio-
graphic OA prevalence and severity. The association between
radiographic and symptomatic OA is weak35. In future studies, it
will be necessary to evaluate symptomatic hand OA. Fourthly, the
studied markers serum levels variations were dependent on
genetic factors. In our previous studies22,24 we showed that the
additive genetic component was associated with a very substantial
variation in MCP-1 (49.25 8.95%), OPG (46.0 9.5%), TNF-
a (82.3 6.7%) and M-CSF (53.8 10.7%). Consequently, it was not
clear that signiﬁcant relationship between the OA degree and OPG
or MCP-1 was due to shared genetic or environmental factors. It is
important to note that although the effect of the above-mentioned
risk factors, particularly RANKL/OPG and inﬂammation markers,
has been previously evaluated, the simultaneous contribution of all
risk factors to OA characteristics has never been assessed. Herein
we have begun the assessment process.
In summary, this study provides support to the statement that
OPG might be a valid biomarker of hand OA. Conﬁrmation of our
results in a larger cohort of patients will validate our premise that
the RANKL/OPG pathway is a suitable target for the development of
novel agents against OA.
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